C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups

Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394)
01/2003
01/08/2003	CN1098251C Method for preparing creatine or its hydrate
01/07/2003	US6504057 Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
01/07/2003	US6503745 Method of detecting influenza virus, comprising the step of exposing a sample suspected to comprise influenza virus to at least one compound according to claim 1, wherein the at least one compound is capable of binding specifically to the active
01/07/2003	US6503713 Methods for identifying RNA binding compounds
01/03/2003	WO2003000643A1 Nitrate ester derivatives useful for preparing drugs for epilepsy
01/02/2003	US20030004376 Method for producing n-methyl-n'-nitroguanidine
01/02/2003	US20030004341 Antidiabetic agents and dietetics
01/02/2003	US20030004308 Anticoagulants
01/02/2003	EP1270552A2 Production process for a guanidine derivative containing an amido group and for a salt thereof
01/02/2003	EP1268414A1 Ceramide derivatives and method of use
01/02/2003	EP1268411A1 Method for producing n-methyl-n'-nitroguanidine
01/02/2003	EP1267854A2 Highly selective inhibitors of the urokinase plasminogen activator
01/01/2003	CN1388118A Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn and use
01/01/2003	CN1097579C Ortho-substituted benzoylguanidines, process for their preparation, use and medicine containing them
01/01/2003	CN1097578C Production process of high-purity creatine and its monohydrate
12/2002
12/31/2002	US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors
12/27/2002	WO2001085095B1 Chiral fluoroquinolizinone arginine salt forms
12/25/2002	CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/24/2002	US6498273 For imaging organs or structures including blood vessels, a thrombus within a vessel, heart, brain, kidney, liver, lungs, spleen, etc., meidcal diagnosis
12/24/2002	US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke
12/18/2002	EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/18/2002	EP1265852A1 Substituted imide derivatives
12/18/2002	EP0859607B1 Guanidino protease inhibitors
12/18/2002	CN1385423A N-(4,6-disubstituted 6 pyrimidine-2-)aniline and intermediate products preparation pocess thereof
12/18/2002	CN1385419A Process for preparing guanidine hydrochloride
12/18/2002	CN1385418A Process for preparing guanidine carbonate
12/17/2002	US6495546 Propanolamine derivatives
12/10/2002	US6492356 Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
12/10/2002	CA2036360C Reagents and methods for stereospecific fluoromethylation
12/05/2002	US20020182425 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
12/04/2002	EP1261647A2 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
12/04/2002	EP1261630A2 Bacterial genes and proteins that are essential for cell viability and their uses
12/04/2002	EP1261581A1 Method for producing 1-methyl-3-nitroguanidine
12/03/2002	US6489495 Cationic amphiphiles for liposomal gene transfer
12/03/2002	US6489339 C3A receptor ligands
12/03/2002	US6489327 Tryptase inhibitors
11/2002
11/28/2002	US20020177627 Microbiocidal properties of poly-substituted guanidinium salts
11/27/2002	EP1017672B1 New npy antagonists
11/26/2002	US6486348 Method for producing 1-methyl-3-nitroguanidine
11/21/2002	WO2002092555A1 Sialic acid derivatives
11/21/2002	US20020173675 Method for producing 1-methyl-3-nitroguanidine
11/21/2002	US20020173647 Polymorphic/pseudopolymorphic forms of arginine salt of 3-(4-(2-(phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoic acid
11/21/2002	US20020173529 Fungicide active substance combinations
11/21/2002	US20020172651 Agent for coloring fibers and method for temporarily coloring fibers
11/20/2002	EP1257529A2 Method for producing nitroguanidine
11/20/2002	EP1042301B1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
11/20/2002	EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/19/2002	CA2155931C Inhibitors of thrombosis
11/13/2002	EP0983232B1 Guanidinylation reagents
11/13/2002	EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/06/2002	EP1254075A1 Nonaborate compositions and their preparation
10/2002
10/31/2002	WO2002085844A1 New compounds
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002068381A3 Aryl-n-cyanoguanidines and methods related thereto
10/30/2002	EP1252137A1 Palatable arginine compounds and uses thereof for cardiovascular health
10/30/2002	CN1376670A Arginine-ketoprofen with antalgic and inflammation relieving actions and its preparing process
10/30/2002	CN1376669A Extracting process and usage of general leonurine
10/29/2002	US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002	US6472427 Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile
10/24/2002	WO2002022626A8 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	CN1376149A 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
10/17/2002	WO2002081483A2 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/16/2002	EP0920434B1 Bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
10/10/2002	WO2001072685A9 Polyamine analogues as cytotoxic agents
10/08/2002	US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide
10/08/2002	US6461585 Preparation of radiolabelled haloaromatics via polymer-bound intermediates
10/03/2002	WO2002076965A1 Non peptide mimetics based on the active sequence s42fllr46 of the thrombin receptor for the treatment of thrombosis and cancer
10/03/2002	WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof
10/03/2002	WO2002076931A1 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
10/03/2002	WO2001085095A3 Chiral fluoroquinolizinone arginine salt forms
10/02/2002	EP1007496B1 New chemical compound, explosive containing the compound and use of the compound in gas generators
10/02/2002	CN1372540A Non-hydroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
10/01/2002	US6458835 Using 4-(((cyanoimino)-((1,2,2-trimethylpropyl)amino) methyl)amino)benzonitrile
10/01/2002	US6458381 Lipids and their use, for example, in liposomes
10/01/2002	CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists
09/2002
09/26/2002	WO2001032717A3 Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith
09/26/2002	US20020137939 Novel guanidinobenzamides
09/26/2002	US20020137784 Guanidine derivatives
09/26/2002	US20020137730 Positively charged non-natural amino acids, methods of making and using thereof in peptides
09/25/2002	EP1242366A1 Salicylamides as serine protease and factor xa inhibitors
09/24/2002	US6455671 Thrombin inhibitors, the preparation and use thereof
09/19/2002	WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes
09/12/2002	WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
09/12/2002	WO2001085728A3 Antibacterial chiral 8-(substituted piperidino)-benzo [i, j] quinolizines, processes, compositions and methods of treatment
09/12/2002	WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses
09/11/2002	EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity
09/11/2002	CN1368962A Fluorene derivatives
09/10/2002	CA2129339C Inhibitors of thrombosis
09/06/2002	WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto
09/06/2002	WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
09/06/2002	CA2475454A1 Aryl-n-cyanoguanidines and methods related thereto
09/05/2002	US20020123529 Anti-arrhythmia, -ischemic, -proliferative and -diabetic agents; cardiotonic, necrosis; angina pectoris; peripheral and central nervous systems; protecting/preserving organs; inhibition of Na+/H+ exchange; diagnosis hypertonia
09/04/2002	EP1236712A1 Amidinophenylpyruvic acid derivative
09/04/2002	EP1235793A2 Vla-4 integrin antagonists
09/04/2002	EP0883602B1 Lipids
09/04/2002	CN1367776A Process for preparing substituted cyclopentane derivatives and novel crystalline structures
08/2002
08/29/2002	WO2002066421A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
08/29/2002	US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002	US20020120009 Compounds and compositions for delivering active agents

1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 54